Canalia 30 mg (Capsule (Enteric Coated))
Unit Price: ৳ 10.00 (6 x 10: ৳ 600.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Dexlansoprazole |
Company | Aristopharma ltd |
Also available as |
Title and Categories
- Canalia (Dexlansoprazole) Capsule
- Proton Pump Inhibitor Medication
- Gastrointestinal Health
Indications
- Healing of Erosive Esophagitis
- Maintenance of Healed Erosive Esophagitis
- Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Dosage Recommendations
- 30 mg Once daily for Maintenance of Healed Erosive Esophagitis and Relief of Heartburn
- 30 mg Once daily for Symptomatic Non-Erosive GERD for 4 weeks
- 60 mg Once daily for Healing of Erosive Esophagitis for up to 8 weeks
- One 30 mg tablet once daily for Maintenance of Healed Erosive Esophagitis and Relief of Heartburn for 6 months in adults
- One 30 mg tablet once daily for Symptomatic Non-Erosive GERD for 4 weeks in patients 12 to 17 years of age
Mode of Action
Dexlansoprazole delayed-release capsule suppresses gastric acid secretion by specific inhibition of the (H+/K+)-ATPase in the gastric parietal cell.
Administration
- Can be taken without regard to food
- Swallowed whole or administered by sprinkling intact granules on one tablespoon and swallowing immediately. Granules should not be chewed.
Interaction
- Atazanavir
- Warfarin
- Tacrolimus
- Clopidogrel
- Methotrexate
Contraindications
Patients with known hypersensitivity to any component of the formulation.
Side Effects
- Diarrhea
- Abdominal pain
- Nausea
- Vomiting
- Flatulence
Pregnancy & Lactation
Pregnancy Category B. No well-controlled studies with Dexlansoprazole in pregnant or lactating women.
Precautions & Warnings
- Gastric Malignancy
- Clostridium difficile Associated Diarrhea
- Bone fracture
- Hypomagnesemia
- Concomitant use with Methotrexate
Use in Special Populations
- Safety and effectiveness in patients below 12 years not established
- No dose adjustment necessary for elderly patients
- No dose adjustment necessary for patients with renal impairment
- No dose adjustment necessary for patients with mild hepatic impairment. Consider maximum daily dose of 30 mg for patients with moderate hepatic impairment.
Overdose Effects
No reports of significant overdose. Multiple doses of Canalia 120 mg and a single dose of Canalia 300 mg did not result in severe adverse events or death.
Therapeutic Class
Proton Pump Inhibitor
Storage Conditions
Store below 30°C temperature, in a dry place, protected from light. Keep out of reach of children.
Related Brands
- Dexnaaf 60 mg (Capsule (Enteric Coated)) - naafco-pharma-ltd
- Dexnaaf 30 mg (Capsule (Enteric Coated)) - naafco-pharma-ltd
- Lansomax 30 mg (Capsule (Enteric Coated)) - concord-pharmaceuticals-ltd
- Dex-PPI 30 mg (Capsule (Enteric Coated)) - chemist-laboratories-ltd
- DLS 30 mg (Capsule (Enteric Coated)) - medicon-pharmaceuticals-ltd